MAO-B — Drug Target

2 drugs 1 marketed 1 in Phase 3

All drugs that target MAO-B — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

MAO-B inhibitor

Marketed (1)

MMI · Xiao-Ming Mao · MAO-B inhibitor · Neurology
MMI is a selective monoamine oxidase B (MAO-B) inhibitor.

Phase 3 pipeline (1)

Safinamide (as add-on therapy) · Newron Pharmaceuticals SPA · MAO-B inhibitor · Neurology
Safinamide is a monoamine oxidase B (MAO-B) inhibitor that also has a weak inhibitory effect on monoamine oxidase A (MAO-A).